It has been hypothesized that locally secreted TGF-β, which induces αE(CD103)β7 expression in non-CNS sites (165), may also moderate αE(CD103)β7 expression on T cells within gliomas (164). The gene discussed is TGFB1; the disease is central nervous system cancer.